Exploration of Targeted Anti-tumor Therapy
SJR0.883
CN
CNJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.883 | Q2 | 80.5% | |
| 2024 | — | — | 0.677 | Q3 | 72.4% | |
| 2023 | — | — | 0.692 | Q2 | 75.4% | |
| 2022 | — | — | — | 5.2% | ||
| 2021 | — | — | — | 6.8% | ||
| 2020 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
2692-3114
country
CNcoverage
2020-2026